LUKAS SIMON to Drug Resistance, Neoplasm
This is a "connection" page, showing publications LUKAS SIMON has written about Drug Resistance, Neoplasm.
Connection Strength
0.608
-
Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer. Mol Cancer Res. 2019 11; 17(11):2318-2330.
Score: 0.439
-
TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma. Blood. 2025 Nov 20; 146(21):2544-2560.
Score: 0.169